A Cyp2a polymorphism predicts susceptibility to NNK-induced lung tumorigenesis in mice

Carcinogenesis

Volumn 32, Issue 8, 2011, Pages 1279-1284

  Hollander, M Christine ^a   Zhou, Xin ^b   Maier, Colleen R ^a   Patterson, Andrew D ^a   Ding, Xinxin ^b   Dennis, Phillip A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; CYTOCHROME P450 2A; CYTOCHROME P450 2A5; ISOPROTEIN; K RAS PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; PROTEIN KINASE B BETA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 7; DNA ADDUCT; DOWNSTREAM PROCESSING; ENZYME POLYMORPHISM; FEMALE; GENE DELETION; GENE MAPPING; GENE MUTATION; IN VIVO STUDY; LUNG CARCINOGENESIS; LUNG TUMOR; MALE; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 79961202687     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr097     Document Type: Article

References (31)

1. Hecht,S.S. (1999) DNA adduct formation from tobacco-specific N-nitrosamines. Mutat. Res., 424, 127-142.
2. Weng,Y. et al. (2007) Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice. Cancer Res., 67, 7825-7832.
3. Wang,H. et al. (2003) Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res., 63, 8057-8061.
4. Kiyohara,C. et al. (2005) CYP2A13, CYP2A6, and the risk of lung adenocarcinoma in a Japanese population. J. Health Sci., 51, 658-666.
5. Lin,L. et al. (1998) Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp. Lung Res., 24, 481-497.
6. Hollander,M.C. et al. (2008) Strain-specific spontaneous and NNKmediated tumorigenesis in Pten+/- mice. Neoplasia, 10, 866-872.
7. Hollander,M.C. et al. (2011) Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene, 30(15), 1812-1821.
8. Johnson,L. et al. (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature, 410, 1111-1116.
9. Massey,T.E. et al. (1995) High frequency of K-ras mutations in spontaneous and vinyl carbamate-induced lung tumors of relatively resistant B6CF1 (C57BL/6J x BALB/cJ) mice. Carcinogenesis, 16, 1065-1069.
10. Cho,H. et al. (2001) Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science, 292, 1728-1731.
11. D'Agostino,J. et al. (2009) The pneumotoxin 3-methylindole is a substrate and a mechanism-based inactivator of CYP2A13, a human cytochrome P450 enzyme preferentially expressed in the respiratory tract. Drug Metab. Dispos., 37, 2018-2027.
12. Miyazaki,M. et al. (2005) Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas. Carcinogenesis, 26, 1947-1955.
13. Felicia,N.D. et al. (2000) Characterization of cytochrome P450 2A4 and 2A5-catalyzed 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism. Arch. Biochem. Biophys., 384, 418-424.
14. He,X.Y. et al. (2004) Identification of critical amino acid residues of human CYP2A13 for the metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific carcinogen. Drug Metab. Dispos., 32, 1516-1521.
15. Takeuchi,H. et al. (2003) Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Cancer Res., 63, 7581-7583.
16. Su,T. et al. (2000) Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res., 60, 5074-5079.
17. Lindberg,R.L. et al. (1992) Molecular characterization of the murine Coh locus: an amino acid difference at position 117 confers high and low coumarin 7-hydroxylase activity in P450coh. Pharmacogenetics, 2, 32-37.
18. Devereux,T. et al. (1993) Comparison of pulmonary O6-methylguanine DNA adduct levels and Ki-ras activation in lung tumors from resistant and susceptible mouse strains. Mol. Carcinog., 8, 177-185.
19. Manenti,G. et al. (2005) Pas1 haplotype-dependent genetic predisposition to lung tumorigenesis in rodents: a meta-analysis. Carcinogenesis, 26, 875-882.
20. Hoffler,U. et al. (2005) Inhibition of urethane-induced genotoxicity and cell proliferation in CYP2E1-null mice. Mutat. Res., 572, 58-72.
21. Ghanayem,B.I. (2007) Inhibition of urethane-induced carcinogenicity in cyp2e1-/- in comparison to cyp2e1+/+ mice. Toxicol. Sci., 95, 331-339.
22. Lu,Y. et al. (2011) Ethanol induction of CYP2A5: permissive role for CYP2E1. Drug Metab. Dispos., 39, 330-336.
23. Lindberg,R.L. et al. (1989) Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue. Nature, 339, 632-634.
24. Zhang,X. et al. (2002) Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant. J. Pharmacol. Exp. Ther., 302, 416-423.
25. Peterson,L.A. et al. (1991) O6-methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res., 51, 5557-5564.
26. Manenti,G. et al. (2009) Mouse genome-wide association mapping needs linkage analysis to avoid false-positive loci. PLoS Genet., 5, e1000331.
27. Rodenhuis,S. et al. (1992) Clinical significance of ras oncogene activation in human lung cancer. Cancer Res., 52, 2665s-2669s.
28. Hung,R.J. et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452, 633-637.
29. Thorgeirsson,T.E. et al. (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature, 452, 638-642.
30. Thorgeirsson,T.E. et al. (2010) Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat. Genet., 42, 448-453.
31. Arredondo,J. et al. (2006) Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells. Cancer Biol. Ther., 5, 511-517.